These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
342 related items for PubMed ID: 9715278
1. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas. Maerz WJ, Baselga J, Reuter VE, Mellado B, Myers ML, Bosl GJ, Spinella MJ, Dmitrovsky E. Oncogene; 1998 Aug 13; 17(6):761-7. PubMed ID: 9715278 [Abstract] [Full Text] [Related]
2. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells. Spinella MJ, Kitareewan S, Mellado B, Sekula D, Khoo KS, Dmitrovsky E. Oncogene; 1998 Jul 02; 16(26):3471-80. PubMed ID: 9692555 [Abstract] [Full Text] [Related]
16. Modulation of differentiation in PA-1 human teratocarcinoma cells after N-ras oncogene-induced tumorigenicity. Tainsky MA, Yim SO, Krizman DB, Kannan P, Chiao PJ, Mukhopadhyay T, Buettner R. Oncogene; 1991 Sep 02; 6(9):1575-82. PubMed ID: 1681491 [Abstract] [Full Text] [Related]
17. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7). Andrews PW, Damjanov I, Berends J, Kumpf S, Zappavigna V, Mavilio F, Sampath K. Lab Invest; 1994 Aug 02; 71(2):243-51. PubMed ID: 7521445 [Abstract] [Full Text] [Related]
18. Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells. Chadalavada RS, Korkola JE, Houldsworth J, Olshen AB, Bosl GJ, Studer L, Chaganti RS. Stem Cells; 2007 Mar 02; 25(3):771-8. PubMed ID: 17138961 [Abstract] [Full Text] [Related]